Loading…
Automated synthesis of [68Ga]Ga-FAPI-46 without pre-purification of the generator eluate on three common synthesis modules and two generator types
Background The recent development of quinoline-based radiotracers, which act as fibroblast activation protein inhibitors (FAPIs), has shown promising preclinical and clinical advantages. [ 68 Ga]Ga-FAPI-46 is a new radiotracer for in vivo detection of the fibroblast activation protein by positron em...
Saved in:
Published in: | EJNMMI radiopharmacy and chemistry 2022-07, Vol.7 (1), p.20-20, Article 20 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background
The recent development of quinoline-based radiotracers, which act as fibroblast activation protein inhibitors (FAPIs), has shown promising preclinical and clinical advantages. [
68
Ga]Ga-FAPI-46 is a new radiotracer for in vivo detection of the fibroblast activation protein by positron emission tomography (PET). Recently, the automated synthesis of [
68
Ga]Ga-FAPI-46 was reported based on pre-concentration and purification of the generator eluate by using a cation exchange-cartridge.
Our aim was to simplify the synthesis and shorten the automated synthesis of [
68
Ga]Ga-FAPI-46 to make it accessible and thus even more attractive to a broader clinical and scientific community.
Results
We developed and evaluated the GMP compliant automatic synthesis of [
68
Ga]Ga-FAPI-46 using two different
68
Ge/
68
Ga generators (an Eckert & Ziegler, GalliaPharm generator, 1.85 GBq/50 mCi and an iThemba generator, 1.85 GBq/50 mCi) Somerset West, South Africa) and three different commercial and customized systems: the EasyOne module from Trasis; the GaSy module from Synthra with a customized synthesis template and a customized single use cassette. Additionally, the automatic synthesis of [
68
Ga]Ga-FAPI-46 was established on a GallElut synthesis module from Scintomics with fixed tubing.
Conclusions
Independent of the synthesis modules or the generators employed we were able to complete the synthesis of [
68
Ga]Ga-FAPI-46 in 12 min including the process of purification and formulation. In all cases, the final products showed more than 99.5% chemical purity and the radiochemical yield reached around 92.5% (decay corrected). All quality control parameters (e.g. sterility, stability and radiochemical purity) were conform to the European Pharmacopoeia. |
---|---|
ISSN: | 2365-421X 2365-421X |
DOI: | 10.1186/s41181-022-00172-1 |